| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhabdomyosarcoma | 18 | 2021 | 382 | 1.890 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 5 | 2021 | 41 | 1.490 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 8 | 2023 | 73 | 1.480 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 6 | 2021 | 102 | 1.400 |
Why?
|
| Lupus Nephritis | 6 | 2022 | 310 | 1.250 |
Why?
|
| Oncogene Proteins, Fusion | 12 | 2014 | 1581 | 0.990 |
Why?
|
| Lupus Erythematosus, Systemic | 13 | 2024 | 2104 | 0.850 |
Why?
|
| Protein Phosphatase 2 | 6 | 2022 | 229 | 0.810 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2019 | 357 | 0.770 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 8 | 2012 | 45 | 0.770 |
Why?
|
| Immunohistochemistry | 42 | 2021 | 11366 | 0.730 |
Why?
|
| Neuroblastoma | 17 | 2016 | 1226 | 0.670 |
Why?
|
| Membrane Glycoproteins | 13 | 2007 | 3768 | 0.630 |
Why?
|
| Autopsy | 5 | 2004 | 1020 | 0.630 |
Why?
|
| Benzylamines | 1 | 2019 | 223 | 0.620 |
Why?
|
| Th17 Cells | 7 | 2023 | 766 | 0.610 |
Why?
|
| Hypothermia | 2 | 2012 | 189 | 0.600 |
Why?
|
| Thrombospondin 1 | 9 | 2012 | 250 | 0.560 |
Why?
|
| Neuroectodermal Tumors, Primitive | 4 | 2009 | 140 | 0.530 |
Why?
|
| T-Lymphocytes, Regulatory | 9 | 2022 | 2988 | 0.520 |
Why?
|
| Sarcoma, Synovial | 2 | 2012 | 167 | 0.480 |
Why?
|
| S100 Proteins | 3 | 2014 | 259 | 0.480 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 2916 | 0.440 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 3 | 2024 | 255 | 0.430 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2012 | 26 | 0.410 |
Why?
|
| Postmortem Changes | 3 | 2001 | 126 | 0.410 |
Why?
|
| Podocytes | 3 | 2021 | 396 | 0.410 |
Why?
|
| Apoptosis | 22 | 2021 | 9727 | 0.400 |
Why?
|
| Tumor Cells, Cultured | 30 | 2016 | 6314 | 0.400 |
Why?
|
| Lactoferrin | 2 | 2002 | 97 | 0.390 |
Why?
|
| Complement Activation | 5 | 2022 | 453 | 0.390 |
Why?
|
| Gene Fusion | 1 | 2014 | 371 | 0.380 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2013 | 736 | 0.380 |
Why?
|
| Arthritis, Experimental | 2 | 2023 | 291 | 0.370 |
Why?
|
| Bone Neoplasms | 14 | 2009 | 2529 | 0.360 |
Why?
|
| Transcription Factors | 9 | 2018 | 12208 | 0.360 |
Why?
|
| Sepsis | 5 | 2002 | 2593 | 0.360 |
Why?
|
| Synovial Fluid | 1 | 2012 | 394 | 0.350 |
Why?
|
| Synovial Membrane | 3 | 2012 | 507 | 0.350 |
Why?
|
| Sulfonamides | 2 | 2019 | 1938 | 0.350 |
Why?
|
| Microscopy, Electron | 26 | 2015 | 2645 | 0.350 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2440 | 0.340 |
Why?
|
| Nanoparticles | 2 | 2019 | 1905 | 0.340 |
Why?
|
| Complement System Proteins | 3 | 2022 | 795 | 0.340 |
Why?
|
| RNA-Binding Protein EWS | 7 | 2012 | 216 | 0.320 |
Why?
|
| Membrane Proteins | 12 | 2021 | 7880 | 0.310 |
Why?
|
| Cause of Death | 6 | 2013 | 3584 | 0.310 |
Why?
|
| T-Lymphocytes | 9 | 2021 | 10180 | 0.310 |
Why?
|
| Mice | 66 | 2024 | 81183 | 0.310 |
Why?
|
| Apoptosis Regulatory Proteins | 6 | 2012 | 1157 | 0.310 |
Why?
|
| Interleukin-2 | 5 | 2022 | 1904 | 0.310 |
Why?
|
| Succinate Dehydrogenase | 3 | 2015 | 146 | 0.300 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2007 | 740 | 0.290 |
Why?
|
| Palatal Neoplasms | 1 | 2006 | 35 | 0.290 |
Why?
|
| Methylmalonyl-CoA Mutase | 2 | 2018 | 22 | 0.290 |
Why?
|
| Palate, Hard | 1 | 2006 | 57 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 1434 | 0.280 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 7 | 2006 | 105 | 0.280 |
Why?
|
| Adolescent | 59 | 2021 | 85781 | 0.270 |
Why?
|
| bcl-Associated Death Protein | 1 | 2006 | 107 | 0.270 |
Why?
|
| DNA, Neoplasm | 8 | 2004 | 1758 | 0.270 |
Why?
|
| Humans | 208 | 2024 | 744343 | 0.270 |
Why?
|
| Erythrocytes | 5 | 2020 | 2455 | 0.270 |
Why?
|
| Autoimmunity | 8 | 2024 | 1349 | 0.270 |
Why?
|
| Soft Tissue Neoplasms | 10 | 2005 | 1363 | 0.270 |
Why?
|
| Fibroblast Growth Factors | 2 | 2024 | 879 | 0.260 |
Why?
|
| Animals | 82 | 2024 | 168757 | 0.260 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2004 | 595 | 0.260 |
Why?
|
| Th1 Cells | 2 | 2021 | 1057 | 0.250 |
Why?
|
| Neoplasms, Muscle Tissue | 2 | 2003 | 83 | 0.250 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2007 | 234 | 0.250 |
Why?
|
| Hemorrhage | 2 | 2012 | 3461 | 0.250 |
Why?
|
| Mice, Inbred MRL lpr | 3 | 2019 | 159 | 0.250 |
Why?
|
| Child | 57 | 2021 | 77709 | 0.250 |
Why?
|
| Mitochondria | 7 | 2022 | 3520 | 0.240 |
Why?
|
| Carcinoma, Small Cell | 3 | 1997 | 420 | 0.240 |
Why?
|
| Erythema | 1 | 2005 | 257 | 0.240 |
Why?
|
| Abdominal Neoplasms | 3 | 2008 | 292 | 0.230 |
Why?
|
| Carrier Proteins | 6 | 2019 | 5021 | 0.230 |
Why?
|
| Reperfusion Injury | 3 | 2017 | 1026 | 0.230 |
Why?
|
| Interleukin-23 | 2 | 2023 | 193 | 0.230 |
Why?
|
| Adult | 81 | 2021 | 214055 | 0.220 |
Why?
|
| Achlorhydria | 2 | 1999 | 11 | 0.220 |
Why?
|
| Phosphofructokinases | 1 | 2022 | 7 | 0.220 |
Why?
|
| Knee Joint | 2 | 2012 | 1680 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2006 | 2915 | 0.220 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 5535 | 0.220 |
Why?
|
| Lipodystrophy | 1 | 2024 | 147 | 0.220 |
Why?
|
| Interleukin-17 | 2 | 2020 | 899 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2003 | 4420 | 0.220 |
Why?
|
| Lectins | 2 | 2022 | 513 | 0.220 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2003 | 93 | 0.220 |
Why?
|
| Kidney Neoplasms | 7 | 2013 | 4262 | 0.210 |
Why?
|
| Heart Injuries | 1 | 2004 | 210 | 0.210 |
Why?
|
| Forensic Medicine | 1 | 2002 | 64 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4751 | 0.210 |
Why?
|
| Mucolipidoses | 2 | 1999 | 82 | 0.210 |
Why?
|
| Mice, Knockout | 18 | 2021 | 14557 | 0.200 |
Why?
|
| Neuroectodermal Tumors | 2 | 2001 | 27 | 0.200 |
Why?
|
| Female | 108 | 2021 | 380194 | 0.200 |
Why?
|
| Muscular Diseases | 2 | 2013 | 556 | 0.200 |
Why?
|
| Gastrins | 2 | 2008 | 81 | 0.200 |
Why?
|
| MyoD Protein | 2 | 2021 | 151 | 0.200 |
Why?
|
| Skin | 6 | 2019 | 4364 | 0.200 |
Why?
|
| Collagen | 5 | 2003 | 2689 | 0.190 |
Why?
|
| Calcium Signaling | 2 | 2021 | 721 | 0.190 |
Why?
|
| Male | 99 | 2021 | 350118 | 0.190 |
Why?
|
| DNA-Binding Proteins | 6 | 2017 | 9648 | 0.190 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2021 | 98 | 0.190 |
Why?
|
| Muramidase | 1 | 2001 | 174 | 0.190 |
Why?
|
| Metalloendopeptidases | 2 | 1999 | 396 | 0.190 |
Why?
|
| Parietal Cells, Gastric | 2 | 1999 | 47 | 0.190 |
Why?
|
| Complement Pathway, Alternative | 1 | 2021 | 126 | 0.190 |
Why?
|
| Nose Neoplasms | 2 | 2001 | 246 | 0.190 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2001 | 143 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 705 | 0.190 |
Why?
|
| Inclusion Bodies | 3 | 2004 | 279 | 0.190 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2000 | 106 | 0.190 |
Why?
|
| Nitric Oxide | 8 | 2020 | 2132 | 0.190 |
Why?
|
| Death, Sudden | 1 | 2002 | 302 | 0.180 |
Why?
|
| Genes, myc | 3 | 2008 | 399 | 0.180 |
Why?
|
| Skin Neoplasms | 3 | 2014 | 5686 | 0.180 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 4 | 2007 | 197 | 0.180 |
Why?
|
| Gastritis, Atrophic | 1 | 1999 | 31 | 0.180 |
Why?
|
| Lung | 5 | 2021 | 9856 | 0.180 |
Why?
|
| Doxorubicin | 6 | 2019 | 2234 | 0.180 |
Why?
|
| Calcitonin | 2 | 2001 | 336 | 0.180 |
Why?
|
| Pulmonary Alveoli | 2 | 2002 | 675 | 0.180 |
Why?
|
| Dendritic Cells | 5 | 2008 | 2725 | 0.180 |
Why?
|
| Child, Preschool | 35 | 2018 | 41006 | 0.170 |
Why?
|
| Forensic Pathology | 2 | 2012 | 27 | 0.170 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 1999 | 56 | 0.170 |
Why?
|
| Interferon-gamma | 5 | 2009 | 3206 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2008 | 4554 | 0.170 |
Why?
|
| RNA, Neoplasm | 6 | 2006 | 769 | 0.170 |
Why?
|
| Muscle Neoplasms | 1 | 2000 | 139 | 0.170 |
Why?
|
| Hemoglobins | 1 | 2005 | 1534 | 0.170 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 2400 | 0.170 |
Why?
|
| Drowning | 1 | 1999 | 27 | 0.170 |
Why?
|
| Kidney Tubules | 1 | 2021 | 488 | 0.170 |
Why?
|
| Mesangial Cells | 1 | 2018 | 24 | 0.170 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2019 | 692 | 0.170 |
Why?
|
| Sarcoma | 9 | 2016 | 1897 | 0.170 |
Why?
|
| Cell Differentiation | 21 | 2024 | 11483 | 0.160 |
Why?
|
| Nanoconjugates | 1 | 2018 | 22 | 0.160 |
Why?
|
| Autophagy | 4 | 2012 | 1300 | 0.160 |
Why?
|
| Lymphopoiesis | 1 | 2019 | 135 | 0.160 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2021 | 223 | 0.160 |
Why?
|
| Pleural Neoplasms | 3 | 2015 | 607 | 0.160 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 553 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 4 | 2009 | 1061 | 0.160 |
Why?
|
| Desmin | 3 | 2007 | 130 | 0.160 |
Why?
|
| Infant | 17 | 2021 | 35136 | 0.160 |
Why?
|
| Response Elements | 2 | 2018 | 312 | 0.160 |
Why?
|
| Signal Transduction | 15 | 2021 | 23403 | 0.160 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1998 | 101 | 0.160 |
Why?
|
| Middle Aged | 47 | 2021 | 213383 | 0.160 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2004 | 794 | 0.150 |
Why?
|
| Bronchi | 1 | 2002 | 840 | 0.150 |
Why?
|
| Autoimmune Diseases | 4 | 2019 | 2133 | 0.150 |
Why?
|
| Kidney | 4 | 2022 | 7186 | 0.150 |
Why?
|
| E-Selectin | 1 | 2000 | 579 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2019 | 573 | 0.150 |
Why?
|
| Nasal Cavity | 1 | 1999 | 313 | 0.150 |
Why?
|
| Leiomyomatosis | 2 | 2010 | 70 | 0.150 |
Why?
|
| Virus Diseases | 2 | 2022 | 711 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 20 | 2020 | 21827 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 6 | 1997 | 135 | 0.150 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 4665 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 9 | 2001 | 1799 | 0.140 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 1155 | 0.140 |
Why?
|
| Thyroid Hormones | 1 | 2019 | 390 | 0.140 |
Why?
|
| Azacitidine | 1 | 2018 | 347 | 0.140 |
Why?
|
| Mucin-1 | 1 | 2021 | 543 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 337 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2001 | 1154 | 0.140 |
Why?
|
| Mice, Nude | 12 | 2015 | 3689 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2004 | 1062 | 0.140 |
Why?
|
| Lymphocyte Activation | 4 | 2021 | 5524 | 0.140 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 18029 | 0.140 |
Why?
|
| Integrins | 1 | 2001 | 846 | 0.140 |
Why?
|
| Neoplasm Proteins | 7 | 2006 | 3703 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 491 | 0.140 |
Why?
|
| Caspases | 4 | 2007 | 928 | 0.140 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 57776 | 0.140 |
Why?
|
| Lung Injury | 1 | 2021 | 436 | 0.140 |
Why?
|
| Macrostomia | 1 | 2015 | 6 | 0.140 |
Why?
|
| Tretinoin | 3 | 2016 | 517 | 0.130 |
Why?
|
| Autoantigens | 1 | 2020 | 892 | 0.130 |
Why?
|
| Hypertelorism | 1 | 2015 | 32 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 2455 | 0.130 |
Why?
|
| Caspase 8 | 3 | 2007 | 195 | 0.130 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2013 | 3143 | 0.130 |
Why?
|
| Fas Ligand Protein | 4 | 2001 | 216 | 0.130 |
Why?
|
| DNA Methylation | 3 | 2019 | 4286 | 0.130 |
Why?
|
| Osteogenesis | 1 | 2023 | 1299 | 0.130 |
Why?
|
| Lysosomes | 2 | 2002 | 893 | 0.130 |
Why?
|
| Hypertrichosis | 1 | 2015 | 25 | 0.130 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 697 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2001 | 612 | 0.130 |
Why?
|
| Aged | 31 | 2021 | 163280 | 0.130 |
Why?
|
| Hirsutism | 1 | 2015 | 69 | 0.130 |
Why?
|
| Immunoglobulin G | 3 | 2024 | 4560 | 0.130 |
Why?
|
| Flow Cytometry | 9 | 2020 | 5974 | 0.130 |
Why?
|
| Emergency Treatment | 2 | 2013 | 517 | 0.130 |
Why?
|
| Cushing Syndrome | 3 | 2005 | 249 | 0.130 |
Why?
|
| Ceramides | 2 | 2016 | 199 | 0.130 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2015 | 46 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2013 | 8428 | 0.130 |
Why?
|
| Chondroma | 1 | 2015 | 58 | 0.130 |
Why?
|
| Skin Abnormalities | 1 | 2015 | 60 | 0.130 |
Why?
|
| Osteosarcoma | 3 | 2009 | 881 | 0.130 |
Why?
|
| Staining and Labeling | 2 | 2018 | 1100 | 0.120 |
Why?
|
| Case-Control Studies | 8 | 2020 | 21746 | 0.120 |
Why?
|
| Complement C3 | 1 | 2016 | 461 | 0.120 |
Why?
|
| Rhabdoid Tumor | 2 | 2012 | 212 | 0.120 |
Why?
|
| Muscle, Skeletal | 4 | 2011 | 4931 | 0.120 |
Why?
|
| Myogenin | 2 | 2007 | 58 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2015 | 2849 | 0.120 |
Why?
|
| Antibodies | 4 | 2009 | 2460 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2016 | 2540 | 0.120 |
Why?
|
| Neoplasm Transplantation | 9 | 2015 | 2085 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 1838 | 0.120 |
Why?
|
| Mesothelioma | 3 | 2015 | 818 | 0.120 |
Why?
|
| Translocation, Genetic | 4 | 2008 | 1420 | 0.120 |
Why?
|
| Ischemia | 3 | 2007 | 1907 | 0.120 |
Why?
|
| Young Adult | 12 | 2021 | 56430 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2564 | 0.120 |
Why?
|
| Blotting, Western | 6 | 2016 | 5179 | 0.120 |
Why?
|
| Phenotype | 10 | 2018 | 16365 | 0.110 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2013 | 31 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 1213 | 0.110 |
Why?
|
| Stomach Neoplasms | 2 | 2015 | 1333 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2018 | 2969 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1999 | 987 | 0.110 |
Why?
|
| Genetic Vectors | 3 | 2008 | 3420 | 0.110 |
Why?
|
| Interleukin-6 | 2 | 2001 | 3200 | 0.110 |
Why?
|
| Eyelid Diseases | 1 | 2015 | 155 | 0.110 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 9734 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 2005 | 162 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2006 | 281 | 0.110 |
Why?
|
| Microsporidia | 1 | 2012 | 6 | 0.110 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 2 | 2003 | 46 | 0.110 |
Why?
|
| Eye Abnormalities | 1 | 2015 | 246 | 0.110 |
Why?
|
| Adenoviridae | 2 | 2007 | 1099 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 65 | 0.110 |
Why?
|
| Demyelinating Diseases | 2 | 2006 | 354 | 0.110 |
Why?
|
| Microsporidiosis | 1 | 2012 | 23 | 0.110 |
Why?
|
| Drug Delivery Systems | 2 | 2019 | 2219 | 0.110 |
Why?
|
| Paraffin Embedding | 3 | 2000 | 299 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 1836 | 0.110 |
Why?
|
| Traumatology | 1 | 2013 | 88 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 7 | 2010 | 2649 | 0.110 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2012 | 17 | 0.110 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2016 | 523 | 0.110 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2012 | 22 | 0.100 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 449 | 0.100 |
Why?
|
| Nerve Sheath Neoplasms | 2 | 2012 | 190 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 4 | 2021 | 1144 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2013 | 277 | 0.100 |
Why?
|
| Calcium Phosphates | 1 | 2013 | 171 | 0.100 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 162 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1999 | 934 | 0.100 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2013 | 365 | 0.100 |
Why?
|
| Antineoplastic Agents | 7 | 2018 | 13695 | 0.100 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2012 | 71 | 0.100 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2012 | 209 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 124 | 0.100 |
Why?
|
| Nevus, Pigmented | 1 | 1993 | 219 | 0.100 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2001 | 49 | 0.100 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 2 | 2004 | 46 | 0.100 |
Why?
|
| Cachexia | 1 | 2013 | 204 | 0.100 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2009 | 177 | 0.100 |
Why?
|
| Fatal Outcome | 6 | 2021 | 1850 | 0.100 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1991 | 23 | 0.100 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 416 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 7 | 2016 | 6171 | 0.100 |
Why?
|
| Retinoblastoma | 2 | 2001 | 318 | 0.100 |
Why?
|
| Intestine, Small | 1 | 2017 | 1241 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1403 | 0.100 |
Why?
|
| Phagocytes | 1 | 2012 | 297 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 3505 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2017 | 2617 | 0.090 |
Why?
|
| Formaldehyde | 3 | 2000 | 353 | 0.090 |
Why?
|
| Pituitary Gland | 3 | 2006 | 665 | 0.090 |
Why?
|
| Leiomyosarcoma | 1 | 2015 | 477 | 0.090 |
Why?
|
| Cell Division | 12 | 2003 | 4568 | 0.090 |
Why?
|
| Gene Rearrangement | 3 | 2012 | 1179 | 0.090 |
Why?
|
| Jurkat Cells | 3 | 2016 | 743 | 0.090 |
Why?
|
| Dilatation, Pathologic | 1 | 2012 | 520 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2727 | 0.090 |
Why?
|
| Cells, Cultured | 13 | 2021 | 19229 | 0.090 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1993 | 340 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 4 | 2001 | 1602 | 0.090 |
Why?
|
| Radiation Tolerance | 2 | 2009 | 486 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2016 | 1270 | 0.090 |
Why?
|
| Ectoderm | 2 | 2000 | 137 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 4 | 2006 | 931 | 0.090 |
Why?
|
| Candidiasis | 1 | 2012 | 366 | 0.090 |
Why?
|
| Sialic Acid Storage Disease | 1 | 2009 | 2 | 0.090 |
Why?
|
| Transplantation, Heterologous | 5 | 2012 | 2382 | 0.090 |
Why?
|
| Fumarate Hydratase | 1 | 2010 | 47 | 0.090 |
Why?
|
| Thymus Neoplasms | 1 | 2012 | 268 | 0.090 |
Why?
|
| Calcium | 3 | 2023 | 5756 | 0.090 |
Why?
|
| Pituitary Neoplasms | 3 | 2004 | 1345 | 0.090 |
Why?
|
| PPAR alpha | 1 | 2011 | 197 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 2538 | 0.090 |
Why?
|
| Prognosis | 9 | 2021 | 29063 | 0.090 |
Why?
|
| Coagulation Protein Disorders | 1 | 2008 | 7 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2013 | 712 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2001 | 3778 | 0.090 |
Why?
|
| Cell Line, Tumor | 12 | 2016 | 16689 | 0.090 |
Why?
|
| Adrenal Cortex Diseases | 2 | 2004 | 13 | 0.090 |
Why?
|
| Leptin | 3 | 2011 | 1599 | 0.090 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2008 | 12 | 0.080 |
Why?
|
| Loss of Heterozygosity | 3 | 2013 | 684 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3870 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2003 | 3712 | 0.080 |
Why?
|
| Radiation Protection | 1 | 2012 | 419 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2012 | 390 | 0.080 |
Why?
|
| rho-Associated Kinases | 2 | 2021 | 279 | 0.080 |
Why?
|
| Organic Anion Transporters | 1 | 2009 | 100 | 0.080 |
Why?
|
| Models, Biological | 4 | 2010 | 9583 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 748 | 0.080 |
Why?
|
| Tissue Survival | 1 | 2008 | 118 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2011 | 302 | 0.080 |
Why?
|
| Gastrinoma | 1 | 2008 | 21 | 0.080 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2008 | 91 | 0.080 |
Why?
|
| Receptors, Interleukin | 2 | 2021 | 245 | 0.080 |
Why?
|
| Endocytosis | 1 | 2013 | 985 | 0.080 |
Why?
|
| Cell Line | 12 | 2021 | 15997 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2022 | 4386 | 0.080 |
Why?
|
| Supratentorial Neoplasms | 1 | 2009 | 160 | 0.080 |
Why?
|
| Neurilemmoma | 1 | 1993 | 547 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2012 | 484 | 0.080 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2004 | 59 | 0.080 |
Why?
|
| Immunotherapy | 3 | 2022 | 4445 | 0.080 |
Why?
|
| Chromaffin Cells | 1 | 2007 | 9 | 0.080 |
Why?
|
| Nelfinavir | 1 | 2007 | 68 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 1416 | 0.080 |
Why?
|
| Spectral Karyotyping | 2 | 2005 | 12 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 530 | 0.080 |
Why?
|
| Thymus Gland | 3 | 2019 | 1267 | 0.080 |
Why?
|
| Neoplasms | 8 | 2018 | 21683 | 0.080 |
Why?
|
| Adenoviridae Infections | 1 | 2008 | 96 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2012 | 2008 | 0.070 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 12072 | 0.070 |
Why?
|
| Insulinoma | 1 | 2008 | 124 | 0.070 |
Why?
|
| Mutation | 6 | 2021 | 29786 | 0.070 |
Why?
|
| Genes | 1 | 1991 | 1893 | 0.070 |
Why?
|
| Kidney Diseases | 3 | 2018 | 2149 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 1182 | 0.070 |
Why?
|
| Tumor Virus Infections | 2 | 2002 | 452 | 0.070 |
Why?
|
| Blotting, Southern | 2 | 1999 | 803 | 0.070 |
Why?
|
| Liver | 5 | 2018 | 7474 | 0.070 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1992 | 501 | 0.070 |
Why?
|
| Paraganglioma | 1 | 2008 | 143 | 0.070 |
Why?
|
| Arabinofuranosyluracil | 2 | 1997 | 10 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 847 | 0.070 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2006 | 81 | 0.070 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 569 | 0.070 |
Why?
|
| Anodontia | 1 | 2006 | 49 | 0.070 |
Why?
|
| Injury Severity Score | 2 | 2014 | 1014 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 643 | 0.070 |
Why?
|
| Lung Neoplasms | 7 | 2015 | 13102 | 0.070 |
Why?
|
| Annexin A5 | 1 | 2006 | 103 | 0.070 |
Why?
|
| RNA, Messenger | 11 | 2006 | 13033 | 0.070 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2006 | 27 | 0.070 |
Why?
|
| Phosphatidylethanolamines | 1 | 2007 | 134 | 0.070 |
Why?
|
| Muscle Relaxation | 1 | 2006 | 142 | 0.070 |
Why?
|
| DNA Primers | 3 | 2013 | 2892 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1987 | 197 | 0.070 |
Why?
|
| Vitamin K | 1 | 2008 | 295 | 0.070 |
Why?
|
| Spinal Nerve Roots | 1 | 2006 | 121 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 1996 | 2948 | 0.070 |
Why?
|
| Symporters | 1 | 2009 | 362 | 0.070 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 215 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 6 | 2012 | 9274 | 0.070 |
Why?
|
| Stomach | 1 | 1991 | 697 | 0.070 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2007 | 205 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 2 | 2019 | 1613 | 0.070 |
Why?
|
| Amyloidosis | 1 | 2013 | 795 | 0.070 |
Why?
|
| Neoplasm Metastasis | 6 | 2008 | 4851 | 0.070 |
Why?
|
| Kidney Transplantation | 2 | 2020 | 4251 | 0.070 |
Why?
|
| Peptide Fragments | 2 | 2014 | 5097 | 0.070 |
Why?
|
| Rigor Mortis | 1 | 2005 | 1 | 0.070 |
Why?
|
| Adenoviruses, Human | 1 | 2008 | 257 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 1999 | 2282 | 0.070 |
Why?
|
| Prospective Studies | 8 | 2020 | 53288 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 11031 | 0.070 |
Why?
|
| Adrenal Glands | 5 | 2005 | 546 | 0.070 |
Why?
|
| Seasons | 1 | 2012 | 1493 | 0.070 |
Why?
|
| Mice, SCID | 5 | 2015 | 2716 | 0.070 |
Why?
|
| alpha-Galactosidase | 1 | 2005 | 57 | 0.070 |
Why?
|
| Wilms Tumor | 2 | 2006 | 373 | 0.070 |
Why?
|
| Autonomic Nervous System | 1 | 1991 | 671 | 0.070 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2006 | 101 | 0.070 |
Why?
|
| Isoenzymes | 5 | 2003 | 1726 | 0.070 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2006 | 152 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 859 | 0.070 |
Why?
|
| Antioxidants | 1 | 2013 | 1663 | 0.060 |
Why?
|
| Cytoplasm | 4 | 1998 | 1539 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 2503 | 0.060 |
Why?
|
| Neural Crest | 1 | 1987 | 275 | 0.060 |
Why?
|
| Bacterial Adhesion | 1 | 2006 | 316 | 0.060 |
Why?
|
| Fabry Disease | 1 | 2005 | 90 | 0.060 |
Why?
|
| Sirtuins | 1 | 2008 | 323 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 1788 | 0.060 |
Why?
|
| Neutrophils | 3 | 2012 | 3719 | 0.060 |
Why?
|
| HIV Protease Inhibitors | 1 | 2007 | 430 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2015 | 5456 | 0.060 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2004 | 25 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2001 | 3701 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2001 | 2886 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 1993 | 2007 | 0.060 |
Why?
|
| Pheochromocytoma | 1 | 2007 | 337 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2009 | 1366 | 0.060 |
Why?
|
| Caspase 9 | 2 | 2003 | 188 | 0.060 |
Why?
|
| Melanoma | 2 | 2022 | 5510 | 0.060 |
Why?
|
| Roseolovirus Infections | 1 | 2004 | 45 | 0.060 |
Why?
|
| Whole-Body Irradiation | 4 | 2012 | 449 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2019 | 249 | 0.060 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 550 | 0.060 |
Why?
|
| NF-kappa B | 3 | 2021 | 2499 | 0.060 |
Why?
|
| Oxyphil Cells | 1 | 2004 | 57 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 1986 | 313 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2008 | 817 | 0.060 |
Why?
|
| Adrenocortical Adenoma | 1 | 2004 | 48 | 0.060 |
Why?
|
| Phosphorylation | 5 | 2020 | 8436 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2012 | 1058 | 0.060 |
Why?
|
| Immunosuppressive Agents | 3 | 2018 | 4149 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2015 | 3023 | 0.060 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 2004 | 36 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1988 | 0.060 |
Why?
|
| Lymphadenitis | 1 | 2004 | 98 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2003 | 4161 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 491 | 0.060 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2003 | 107 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2009 | 1038 | 0.060 |
Why?
|
| Hyperplasia | 3 | 2004 | 1185 | 0.060 |
Why?
|
| Cell Line, Transformed | 3 | 2018 | 898 | 0.060 |
Why?
|
| DNA Repair | 1 | 2013 | 2046 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 913 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2014 | 11524 | 0.060 |
Why?
|
| Lymph Nodes | 4 | 2004 | 3474 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 1987 | 647 | 0.060 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 808 | 0.060 |
Why?
|
| Asthma | 1 | 2002 | 6011 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2016 | 0.060 |
Why?
|
| Sternum | 1 | 2004 | 177 | 0.060 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 2 | 1995 | 41 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1620 | 0.060 |
Why?
|
| Endocardium | 1 | 2004 | 263 | 0.060 |
Why?
|
| Liposomes | 1 | 2007 | 759 | 0.060 |
Why?
|
| Gene Amplification | 2 | 1999 | 1063 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2019 | 835 | 0.060 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2007 | 298 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2006 | 2050 | 0.060 |
Why?
|
| Endothelial Cells | 2 | 2013 | 3479 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2003 | 215 | 0.060 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2004 | 213 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2008 | 3772 | 0.050 |
Why?
|
| Periodicity | 1 | 2004 | 363 | 0.050 |
Why?
|
| Lymphoma | 5 | 2001 | 1877 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 2 | 1999 | 1041 | 0.050 |
Why?
|
| Up-Regulation | 6 | 2012 | 4217 | 0.050 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2003 | 119 | 0.050 |
Why?
|
| Drug Resistance | 3 | 1994 | 1609 | 0.050 |
Why?
|
| Trifluoroacetic Acid | 1 | 2002 | 6 | 0.050 |
Why?
|
| Choristoma | 1 | 2004 | 213 | 0.050 |
Why?
|
| Cytodiagnosis | 1 | 2006 | 435 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 4479 | 0.050 |
Why?
|
| Skin Transplantation | 1 | 2008 | 1074 | 0.050 |
Why?
|
| Simian virus 40 | 1 | 2002 | 295 | 0.050 |
Why?
|
| Mice, Mutant Strains | 3 | 2021 | 1866 | 0.050 |
Why?
|
| Exocrine Glands | 1 | 2002 | 50 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2009 | 1821 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 188 | 0.050 |
Why?
|
| Pelvic Neoplasms | 2 | 1999 | 254 | 0.050 |
Why?
|
| Leukocytes | 2 | 2001 | 2043 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2645 | 0.050 |
Why?
|
| Germany | 1 | 2004 | 862 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2008 | 1813 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14722 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 167 | 0.050 |
Why?
|
| Malacoplakia | 1 | 2001 | 15 | 0.050 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 6622 | 0.050 |
Why?
|
| Cytokines | 4 | 2023 | 7322 | 0.050 |
Why?
|
| Gene Expression | 6 | 2011 | 7799 | 0.050 |
Why?
|
| BK Virus | 1 | 2002 | 129 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 1983 | 324 | 0.050 |
Why?
|
| Ganglioneuroblastoma | 1 | 2001 | 10 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2008 | 594 | 0.050 |
Why?
|
| Blotting, Northern | 4 | 1998 | 1581 | 0.050 |
Why?
|
| Autoantibodies | 3 | 2020 | 2035 | 0.050 |
Why?
|
| Multiple Trauma | 1 | 2004 | 367 | 0.050 |
Why?
|
| Hindlimb | 3 | 2008 | 504 | 0.050 |
Why?
|
| Clone Cells | 2 | 2003 | 1692 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 128 | 0.050 |
Why?
|
| Macrophages | 3 | 2020 | 5655 | 0.050 |
Why?
|
| Coatomer Protein | 1 | 2021 | 18 | 0.050 |
Why?
|
| Base Sequence | 7 | 2015 | 12797 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 1917 | 0.050 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 18111 | 0.050 |
Why?
|
| Vulvar Diseases | 1 | 2001 | 61 | 0.050 |
Why?
|
| Thalidomide | 1 | 2006 | 890 | 0.050 |
Why?
|
| Arginase | 1 | 2021 | 79 | 0.050 |
Why?
|
| Treatment Outcome | 8 | 2018 | 63114 | 0.050 |
Why?
|
| Gastroscopy | 2 | 1999 | 207 | 0.050 |
Why?
|
| Complement Inactivating Agents | 1 | 2021 | 50 | 0.050 |
Why?
|
| Discriminant Analysis | 1 | 2001 | 235 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 192 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 655 | 0.050 |
Why?
|
| Adenoma | 2 | 2004 | 2174 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2001 | 58 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2001 | 347 | 0.050 |
Why?
|
| Survival Analysis | 6 | 2005 | 10252 | 0.050 |
Why?
|
| Abdominal Muscles | 1 | 2001 | 166 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2001 | 193 | 0.050 |
Why?
|
| Urinary Bladder Diseases | 1 | 2001 | 166 | 0.050 |
Why?
|
| Cyclic AMP | 2 | 1995 | 1472 | 0.050 |
Why?
|
| Fucose | 1 | 2021 | 125 | 0.050 |
Why?
|
| Integrin alpha4beta1 | 1 | 2001 | 121 | 0.050 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2001 | 82 | 0.050 |
Why?
|
| Phagocytosis | 2 | 2001 | 1539 | 0.050 |
Why?
|
| Lung Diseases, Fungal | 1 | 2001 | 122 | 0.050 |
Why?
|
| Vaginal Diseases | 1 | 2001 | 102 | 0.050 |
Why?
|
| Diagnosis, Differential | 7 | 2012 | 12959 | 0.050 |
Why?
|
| Polyomavirus Infections | 1 | 2002 | 197 | 0.050 |
Why?
|
| Linear Models | 2 | 2001 | 5952 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 625 | 0.050 |
Why?
|
| Lovastatin | 1 | 2000 | 120 | 0.050 |
Why?
|
| U937 Cells | 2 | 2012 | 268 | 0.050 |
Why?
|
| Neoplasms, Experimental | 2 | 2015 | 1276 | 0.050 |
Why?
|
| Hypogonadism | 1 | 2006 | 799 | 0.050 |
Why?
|
| Enterochromaffin-like Cells | 1 | 1999 | 4 | 0.050 |
Why?
|
| Caffeic Acids | 1 | 2000 | 13 | 0.050 |
Why?
|
| Phenylethyl Alcohol | 1 | 2000 | 13 | 0.050 |
Why?
|
| Aging | 2 | 2011 | 8664 | 0.050 |
Why?
|
| Cell Proliferation | 5 | 2022 | 10481 | 0.050 |
Why?
|
| Keratins | 3 | 1997 | 515 | 0.050 |
Why?
|
| Ubiquitin-Activating Enzymes | 2 | 2012 | 83 | 0.050 |
Why?
|
| Myocardium | 2 | 2011 | 4776 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2007 | 1053 | 0.050 |
Why?
|
| Genes, p53 | 2 | 1993 | 755 | 0.050 |
Why?
|
| Hymecromone | 1 | 2019 | 9 | 0.050 |
Why?
|
| Ploidies | 2 | 2008 | 281 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1504 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2001 | 3748 | 0.040 |
Why?
|
| Microscopy | 1 | 2005 | 903 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2022 | 793 | 0.040 |
Why?
|
| Gastric Fundus | 1 | 1999 | 39 | 0.040 |
Why?
|
| Galactose | 1 | 2021 | 306 | 0.040 |
Why?
|
| Necrosis | 4 | 2008 | 1643 | 0.040 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2001 | 199 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 1987 | 2126 | 0.040 |
Why?
|
| Cancer Vaccines | 2 | 2011 | 1023 | 0.040 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2020 | 112 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 996 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 241 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2007 | 1640 | 0.040 |
Why?
|
| Pericardium | 1 | 2004 | 667 | 0.040 |
Why?
|
| Leukopoiesis | 1 | 1999 | 56 | 0.040 |
Why?
|
| Calcimycin | 1 | 1999 | 222 | 0.040 |
Why?
|
| Lipids | 1 | 2011 | 3305 | 0.040 |
Why?
|
| Ionophores | 1 | 1999 | 108 | 0.040 |
Why?
|
| Bucladesine | 3 | 1992 | 121 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 1987 | 1741 | 0.040 |
Why?
|
| Time Factors | 7 | 2007 | 40075 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 272 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 6386 | 0.040 |
Why?
|
| Cell Survival | 5 | 2008 | 5882 | 0.040 |
Why?
|
| Aspergillosis | 1 | 2001 | 235 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 154 | 0.040 |
Why?
|
| Disintegrins | 1 | 2019 | 25 | 0.040 |
Why?
|
| G1 Phase | 1 | 2000 | 415 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 2000 | 241 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 410 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 1999 | 57 | 0.040 |
Why?
|
| Epithelium | 2 | 2002 | 1679 | 0.040 |
Why?
|
| Naphthoquinones | 1 | 2019 | 77 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 225 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2013 | 767 | 0.040 |
Why?
|
| Phenanthrolines | 1 | 1998 | 55 | 0.040 |
Why?
|
| Back | 1 | 1999 | 66 | 0.040 |
Why?
|
| Phenylbutyrates | 1 | 1999 | 69 | 0.040 |
Why?
|
| Retinal Neoplasms | 1 | 2001 | 144 | 0.040 |
Why?
|
| Neck | 1 | 2003 | 697 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2002 | 287 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 9438 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 433 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2020 | 494 | 0.040 |
Why?
|
| Pyrroles | 2 | 2012 | 1146 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1998 | 68 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 1999 | 59 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 640 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 1878 | 0.040 |
Why?
|
| Morbidity | 1 | 2004 | 1769 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 2 | 2008 | 5256 | 0.040 |
Why?
|
| Survival Rate | 5 | 2008 | 12788 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2016 | 2109 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2019 | 462 | 0.040 |
Why?
|
| Isoflurane | 1 | 2002 | 380 | 0.040 |
Why?
|
| Body Weight | 3 | 2011 | 4669 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2001 | 306 | 0.040 |
Why?
|
| Infant, Newborn | 7 | 2020 | 25625 | 0.040 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 2077 | 0.040 |
Why?
|
| Neck Muscles | 1 | 1999 | 104 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 259 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1998 | 149 | 0.040 |
Why?
|
| Respiratory Muscles | 1 | 1999 | 139 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 453 | 0.040 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2018 | 87 | 0.040 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2000 | 314 | 0.040 |
Why?
|
| Combined Modality Therapy | 8 | 2016 | 8642 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2024 | 986 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2012 | 1086 | 0.040 |
Why?
|
| Point Mutation | 1 | 2003 | 1623 | 0.040 |
Why?
|
| Antigens, Differentiation | 2 | 1999 | 927 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1999 | 643 | 0.040 |
Why?
|
| Heart Atria | 1 | 2004 | 1357 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 1999 | 286 | 0.040 |
Why?
|
| Laryngeal Muscles | 1 | 1999 | 98 | 0.040 |
Why?
|
| Leukemia | 1 | 2006 | 1511 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 644 | 0.040 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 1998 | 87 | 0.040 |
Why?
|
| Cholesterol | 3 | 2003 | 2917 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 206 | 0.040 |
Why?
|
| In Situ Hybridization | 4 | 2006 | 1950 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 844 | 0.040 |
Why?
|
| Hernia, Inguinal | 1 | 2000 | 210 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2004 | 1826 | 0.040 |
Why?
|
| Butyrates | 2 | 1990 | 163 | 0.040 |
Why?
|
| Inflammation | 3 | 2023 | 10638 | 0.040 |
Why?
|
| Cyclic GMP | 2 | 2009 | 409 | 0.040 |
Why?
|
| Movement Disorders | 1 | 2001 | 445 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 537 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 6114 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 377 | 0.040 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2017 | 101 | 0.040 |
Why?
|
| Antiviral Agents | 3 | 2007 | 2987 | 0.040 |
Why?
|
| Transgenes | 2 | 2013 | 1009 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1999 | 442 | 0.040 |
Why?
|
| Burkitt Lymphoma | 1 | 1999 | 327 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 253 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2016 | 1682 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2000 | 704 | 0.040 |
Why?
|
| Shoulder | 1 | 1999 | 299 | 0.040 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 248 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2002 | 570 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 140 | 0.040 |
Why?
|
| Metabolism | 1 | 1998 | 196 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2001 | 730 | 0.040 |
Why?
|
| Colonic Neoplasms | 3 | 2001 | 2541 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2007 | 5172 | 0.040 |
Why?
|
| Trans-Activators | 3 | 2011 | 2924 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 13815 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2020 | 805 | 0.040 |
Why?
|
| Transfection | 2 | 2003 | 5892 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 1681 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 335 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1998 | 348 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 3 | 2013 | 2765 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6234 | 0.030 |
Why?
|
| Gaucher Disease | 1 | 1996 | 112 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2018 | 698 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1791 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 387 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1995 | 76 | 0.030 |
Why?
|
| Gangliosides | 1 | 2016 | 137 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 1996 | 177 | 0.030 |
Why?
|
| Cathepsins | 1 | 2016 | 241 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 1998 | 494 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 1660 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 1995 | 108 | 0.030 |
Why?
|
| Arm | 1 | 1999 | 589 | 0.030 |
Why?
|
| Rosette Formation | 2 | 1986 | 153 | 0.030 |
Why?
|
| Electron Transport Complex II | 1 | 2015 | 48 | 0.030 |
Why?
|
| Sural Nerve | 2 | 2006 | 106 | 0.030 |
Why?
|
| Proteinuria | 1 | 2018 | 658 | 0.030 |
Why?
|
| Retina | 1 | 1986 | 2616 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2015 | 3128 | 0.030 |
Why?
|
| Suramin | 1 | 1994 | 34 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 827 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 584 | 0.030 |
Why?
|
| Herpesviridae Infections | 1 | 1996 | 277 | 0.030 |
Why?
|
| Spleen | 2 | 2019 | 2362 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 694 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 390 | 0.030 |
Why?
|
| Escherichia coli | 3 | 2013 | 4217 | 0.030 |
Why?
|
| Salivary Glands | 1 | 1996 | 229 | 0.030 |
Why?
|
| Vimentin | 2 | 1996 | 261 | 0.030 |
Why?
|
| Thoracic Neoplasms | 2 | 1987 | 268 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 3557 | 0.030 |
Why?
|
| Complement C3b | 1 | 2014 | 106 | 0.030 |
Why?
|
| Acute Disease | 2 | 2002 | 7149 | 0.030 |
Why?
|
| Acidosis, Lactic | 1 | 1995 | 142 | 0.030 |
Why?
|
| Endopeptidases | 2 | 2000 | 772 | 0.030 |
Why?
|
| Neurons | 7 | 2001 | 9338 | 0.030 |
Why?
|
| Complement C4b | 1 | 2014 | 135 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2007 | 6895 | 0.030 |
Why?
|
| DNA, Viral | 5 | 2002 | 2225 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1993 | 76 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2003 | 2038 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 1994 | 220 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 2008 | 1423 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2006 | 3462 | 0.030 |
Why?
|
| Berlin | 1 | 2013 | 23 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 35421 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2008 | 437 | 0.030 |
Why?
|
| Leg | 1 | 1999 | 1116 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2000 | 1082 | 0.030 |
Why?
|
| Hepatitis B | 2 | 1997 | 695 | 0.030 |
Why?
|
| Antigens, CD | 3 | 2001 | 4026 | 0.030 |
Why?
|
| Liver Failure | 1 | 1995 | 241 | 0.030 |
Why?
|
| Drugs, Investigational | 1 | 1995 | 214 | 0.030 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1995 | 151 | 0.030 |
Why?
|
| Neurosecretory Systems | 2 | 1993 | 231 | 0.030 |
Why?
|
| RNA Interference | 2 | 2012 | 2889 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 225 | 0.030 |
Why?
|
| Niemann-Pick Diseases | 1 | 1992 | 28 | 0.030 |
Why?
|
| Vasodilation | 2 | 2007 | 944 | 0.030 |
Why?
|
| Recurrence | 3 | 2008 | 8340 | 0.030 |
Why?
|
| Syndrome | 3 | 2008 | 3251 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2021 | 3690 | 0.030 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 1992 | 17 | 0.030 |
Why?
|
| Mesenchymoma | 1 | 1993 | 47 | 0.030 |
Why?
|
| Ganglioneuroma | 1 | 1993 | 57 | 0.030 |
Why?
|
| Biopsy | 3 | 2001 | 6756 | 0.030 |
Why?
|
| Pepsin A | 1 | 1992 | 71 | 0.030 |
Why?
|
| Histocytochemistry | 3 | 1994 | 719 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2008 | 569 | 0.030 |
Why?
|
| Nitrites | 1 | 2012 | 160 | 0.030 |
Why?
|
| Iron | 1 | 2001 | 1774 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1994 | 271 | 0.030 |
Why?
|
| Ligands | 1 | 1999 | 3282 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2004 | 1947 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3798 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 893 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17446 | 0.030 |
Why?
|
| Nephritis, Interstitial | 1 | 2013 | 156 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2012 | 91 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1995 | 731 | 0.030 |
Why?
|
| Ubiquinone | 1 | 2013 | 188 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2006 | 964 | 0.030 |
Why?
|
| Pilot Projects | 4 | 2009 | 8324 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2008 | 2839 | 0.030 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2013 | 124 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2001 | 1061 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2007 | 319 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 169 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 1903 | 0.030 |
Why?
|
| Maryland | 1 | 2012 | 276 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2012 | 258 | 0.030 |
Why?
|
| Cattle | 2 | 2008 | 3922 | 0.020 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2011 | 23 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2007 | 3445 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2002 | 9146 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 1998 | 1173 | 0.020 |
Why?
|
| Phagosomes | 1 | 2012 | 193 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2020 | 2258 | 0.020 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 1970 | 0.020 |
Why?
|
| Cytochromes b | 1 | 2011 | 36 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 6473 | 0.020 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2011 | 49 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 2018 | 901 | 0.020 |
Why?
|
| Molecular Probes | 1 | 1993 | 316 | 0.020 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2011 | 69 | 0.020 |
Why?
|
| Cytarabine | 1 | 1993 | 692 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 496 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2000 | 1563 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2000 | 3279 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2012 | 411 | 0.020 |
Why?
|
| Karyotyping | 2 | 2008 | 1243 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1991 | 287 | 0.020 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1991 | 89 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4803 | 0.020 |
Why?
|
| Butyric Acid | 2 | 1990 | 55 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2012 | 10943 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6365 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2013 | 802 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 2866 | 0.020 |
Why?
|
| Dimethylformamide | 1 | 1990 | 21 | 0.020 |
Why?
|
| Pyridines | 2 | 2012 | 2825 | 0.020 |
Why?
|
| Oncogenes | 2 | 1993 | 1265 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2011 | 180 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1998 | 2015 | 0.020 |
Why?
|
| Paraproteinemias | 1 | 2013 | 246 | 0.020 |
Why?
|
| Liver Transplantation | 2 | 2018 | 2119 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 417 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2011 | 424 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2012 | 527 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2013 | 20129 | 0.020 |
Why?
|
| Disease Progression | 3 | 2020 | 13284 | 0.020 |
Why?
|
| Omentum | 1 | 1991 | 170 | 0.020 |
Why?
|
| Superoxides | 1 | 2011 | 387 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1375 | 0.020 |
Why?
|
| Lipidoses | 1 | 1989 | 10 | 0.020 |
Why?
|
| Osteolysis | 1 | 1991 | 270 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1991 | 235 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2000 | 2716 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1119 | 0.020 |
Why?
|
| Candida albicans | 1 | 2012 | 394 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2005 | 77449 | 0.020 |
Why?
|
| Xanthomatosis | 1 | 1989 | 32 | 0.020 |
Why?
|
| Carbon-Carbon Ligases | 1 | 2008 | 20 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1992 | 1663 | 0.020 |
Why?
|
| Proteins | 2 | 2002 | 6103 | 0.020 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2009 | 39 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 414 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 528 | 0.020 |
Why?
|
| Metanephrine | 1 | 2008 | 26 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 940 | 0.020 |
Why?
|
| Energy Metabolism | 2 | 2011 | 2899 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 538 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2001 | 417 | 0.020 |
Why?
|
| Tongue Diseases | 1 | 1989 | 67 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1992 | 780 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 695 | 0.020 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2008 | 107 | 0.020 |
Why?
|
| Pedigree | 2 | 2008 | 4644 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 4933 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1993 | 907 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2011 | 370 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 598 | 0.020 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1987 | 8 | 0.020 |
Why?
|
| Defective Viruses | 1 | 2008 | 112 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2007 | 1547 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2013 | 575 | 0.020 |
Why?
|
| Cell Size | 2 | 2000 | 643 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3340 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2008 | 197 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 749 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 2124 | 0.020 |
Why?
|
| X-Rays | 1 | 2008 | 301 | 0.020 |
Why?
|
| HLA-DR Antigens | 2 | 2006 | 645 | 0.020 |
Why?
|
| Catecholamines | 1 | 2008 | 387 | 0.020 |
Why?
|
| Starvation | 1 | 2008 | 134 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 272 | 0.020 |
Why?
|
| Epigenomics | 1 | 2013 | 903 | 0.020 |
Why?
|
| Blood Component Removal | 1 | 2008 | 125 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1097 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2012 | 986 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2008 | 375 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2008 | 242 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1678 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1992 | 789 | 0.020 |
Why?
|
| Melanosomes | 1 | 2007 | 31 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1995 | 1381 | 0.020 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2007 | 39 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1987 | 150 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2015 | 4011 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 1995 | 6364 | 0.020 |
Why?
|
| Escherichia coli K12 | 1 | 2006 | 34 | 0.020 |
Why?
|
| Tritium | 1 | 2007 | 745 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 3386 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 2007 | 290 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 1378 | 0.020 |
Why?
|
| Adrenalectomy | 2 | 2004 | 341 | 0.020 |
Why?
|
| Ligation | 1 | 2007 | 453 | 0.020 |
Why?
|
| Schwann Cells | 1 | 1987 | 195 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2006 | 121 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1986 | 124 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 329 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 687 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2007 | 258 | 0.020 |
Why?
|
| Cell Death | 2 | 2006 | 1706 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2008 | 246 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 2008 | 355 | 0.020 |
Why?
|
| World Health Organization | 1 | 1992 | 1318 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2007 | 287 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2006 | 117 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 507 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2008 | 2967 | 0.020 |
Why?
|
| Hemangioblastoma | 1 | 2006 | 70 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 944 | 0.020 |
Why?
|
| Vaccines, DNA | 1 | 2008 | 305 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2001 | 821 | 0.020 |
Why?
|
| Human Growth Hormone | 2 | 2004 | 683 | 0.020 |
Why?
|
| Extracellular Space | 2 | 2000 | 594 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 1994 | 1912 | 0.020 |
Why?
|
| Microvilli | 1 | 1986 | 241 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2216 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 1730 | 0.020 |
Why?
|
| Laminin | 1 | 1987 | 419 | 0.020 |
Why?
|
| Pyrimidines | 1 | 1998 | 2942 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 6487 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1992 | 2373 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 1538 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2007 | 573 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 251 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 1782 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2170 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 563 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2017 | 2958 | 0.020 |
Why?
|
| Actins | 2 | 2006 | 2121 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3647 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2005 | 278 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2006 | 290 | 0.020 |
Why?
|
| Gene Frequency | 1 | 1992 | 3588 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 1085 | 0.020 |
Why?
|
| Rats | 4 | 2007 | 24260 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2007 | 563 | 0.020 |
Why?
|
| Cells | 1 | 1986 | 168 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1801 | 0.020 |
Why?
|
| Pregnancy | 1 | 2006 | 29144 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1991 | 665 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 2006 | 2635 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 5853 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2007 | 909 | 0.020 |
Why?
|
| Genotype | 2 | 2013 | 12951 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2006 | 381 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 1986 | 219 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 11727 | 0.020 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 320 | 0.010 |
Why?
|
| Herpesvirus 6, Human | 1 | 2004 | 95 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1993 | 1519 | 0.010 |
Why?
|
| Melanocytes | 1 | 1987 | 515 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2000 | 8301 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 1525 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 2008 | 4186 | 0.010 |
Why?
|
| Indoles | 1 | 2012 | 1839 | 0.010 |
Why?
|
| Zebrafish | 1 | 2015 | 2994 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1941 | 0.010 |
Why?
|
| Fibronectins | 1 | 1987 | 726 | 0.010 |
Why?
|
| Fluorescence | 1 | 1986 | 751 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1995 | 1596 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 916 | 0.010 |
Why?
|
| Sterols | 1 | 2003 | 63 | 0.010 |
Why?
|
| Tyrphostins | 1 | 2003 | 67 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 693 | 0.010 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2003 | 30 | 0.010 |
Why?
|
| Cytosol | 1 | 2006 | 901 | 0.010 |
Why?
|
| Immunoglobulins | 2 | 1999 | 881 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1996 | 3110 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1983 | 190 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 845 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2472 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1998 | 648 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 128 | 0.010 |
Why?
|
| Myoglobin | 1 | 1983 | 160 | 0.010 |
Why?
|
| DNA | 3 | 2005 | 7301 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 627 | 0.010 |
Why?
|
| Filipin | 1 | 2002 | 13 | 0.010 |
Why?
|
| Dehydrocholesterols | 1 | 2002 | 20 | 0.010 |
Why?
|
| JC Virus | 1 | 2002 | 85 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2008 | 1125 | 0.010 |
Why?
|
| Immune Sera | 1 | 1983 | 641 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 658 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2327 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2003 | 475 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 1224 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 292 | 0.010 |
Why?
|
| Particle Size | 1 | 2007 | 1642 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 6459 | 0.010 |
Why?
|
| Ifosfamide | 2 | 1996 | 228 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 251 | 0.010 |
Why?
|
| Chromogranins | 2 | 1994 | 160 | 0.010 |
Why?
|
| Extremities | 1 | 1987 | 865 | 0.010 |
Why?
|
| Heterozygote | 1 | 2008 | 2804 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2007 | 1402 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2007 | 1438 | 0.010 |
Why?
|
| Cell Count | 2 | 1996 | 1856 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2007 | 743 | 0.010 |
Why?
|
| Cerebellar Neoplasms | 1 | 2006 | 587 | 0.010 |
Why?
|
| Cell Adhesion | 2 | 2000 | 3144 | 0.010 |
Why?
|
| Body Composition | 1 | 2011 | 2401 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 2001 | 74 | 0.010 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2001 | 41 | 0.010 |
Why?
|
| Myosins | 1 | 1983 | 409 | 0.010 |
Why?
|
| Transaminases | 1 | 2002 | 199 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1117 | 0.010 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2001 | 36 | 0.010 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2001 | 32 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 547 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2003 | 626 | 0.010 |
Why?
|
| Etoposide | 2 | 1996 | 641 | 0.010 |
Why?
|
| Protein Transport | 1 | 2007 | 1988 | 0.010 |
Why?
|
| Carbachol | 1 | 2001 | 226 | 0.010 |
Why?
|
| Acromegaly | 1 | 2004 | 346 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1375 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2001 | 156 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2001 | 230 | 0.010 |
Why?
|
| Genes, Retinoblastoma | 1 | 2001 | 136 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 2187 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1983 | 694 | 0.010 |
Why?
|
| Mitotic Index | 1 | 2000 | 172 | 0.010 |
Why?
|
| Neuroglia | 1 | 1986 | 927 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1114 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2000 | 116 | 0.010 |
Why?
|
| Retroviridae Proteins | 1 | 2000 | 98 | 0.010 |
Why?
|
| Vincristine | 2 | 1996 | 1039 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2002 | 528 | 0.010 |
Why?
|
| Down-Regulation | 2 | 2000 | 3002 | 0.010 |
Why?
|
| Trigeminal Ganglion | 1 | 2001 | 186 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 77 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 351 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 1607 | 0.010 |
Why?
|
| Hormones | 1 | 2004 | 889 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2001 | 150 | 0.010 |
Why?
|
| Carrageenan | 1 | 2000 | 67 | 0.010 |
Why?
|
| Sheep | 1 | 1983 | 1437 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2003 | 607 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 323 | 0.010 |
Why?
|
| Putamen | 1 | 2001 | 291 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1995 | 2505 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3086 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 365 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 668 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 2003 | 652 | 0.010 |
Why?
|
| Patient Selection | 1 | 2012 | 4215 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1294 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 682 | 0.010 |
Why?
|
| Ciprofloxacin | 1 | 2001 | 315 | 0.010 |
Why?
|
| Endostatins | 1 | 2000 | 174 | 0.010 |
Why?
|
| Remission Induction | 1 | 2005 | 2386 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1986 | 1504 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2001 | 224 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5317 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2009 | 2948 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2001 | 384 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2008 | 1580 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1940 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 365 | 0.010 |
Why?
|
| Antigens | 1 | 1984 | 1466 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1992 | 12245 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 1785 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 2000 | 360 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2000 | 275 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 1071 | 0.010 |
Why?
|
| Viral Matrix Proteins | 1 | 1999 | 186 | 0.010 |
Why?
|
| Cyclins | 1 | 2000 | 603 | 0.010 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 1998 | 36 | 0.010 |
Why?
|
| Echocardiography | 1 | 2011 | 5102 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2925 | 0.010 |
Why?
|
| Ferritins | 1 | 2001 | 590 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2005 | 2290 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 657 | 0.010 |
Why?
|
| Gastric Acid | 1 | 1998 | 104 | 0.010 |
Why?
|
| Duodenum | 1 | 2001 | 483 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 1526 | 0.010 |
Why?
|
| Virus Activation | 1 | 1999 | 319 | 0.010 |
Why?
|
| Corticosterone | 1 | 1998 | 310 | 0.010 |
Why?
|
| Graft Survival | 1 | 2008 | 3737 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2001 | 517 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 1637 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2002 | 546 | 0.010 |
Why?
|
| Cyclophosphamide | 2 | 1996 | 2242 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2000 | 532 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1998 | 1101 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 3479 | 0.010 |
Why?
|
| Cyclohexanes | 1 | 1996 | 152 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4740 | 0.010 |
Why?
|
| Diethylamines | 1 | 1995 | 3 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1996 | 240 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit | 1 | 1995 | 7 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 1996 | 115 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
| DNA Damage | 2 | 1996 | 2432 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2000 | 1588 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 1995 | 26 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 1641 | 0.010 |
Why?
|
| Thymidine | 1 | 1995 | 310 | 0.010 |
Why?
|
| Siderophores | 1 | 1995 | 57 | 0.010 |
Why?
|
| Jaundice | 1 | 1995 | 89 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3508 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2478 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2000 | 2557 | 0.010 |
Why?
|
| Catalase | 1 | 1995 | 222 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1995 | 151 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1993 | 1475 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 1990 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 707 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 4189 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 4894 | 0.010 |
Why?
|
| Thalamus | 1 | 2001 | 1023 | 0.010 |
Why?
|
| Virus Replication | 1 | 2002 | 2534 | 0.010 |
Why?
|
| Chromogranin A | 1 | 1994 | 54 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 2000 | 971 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2000 | 1355 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 1995 | 252 | 0.010 |
Why?
|
| Classification | 1 | 1994 | 129 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 1997 | 629 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 1994 | 103 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2002 | 4776 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1993 | 91 | 0.010 |
Why?
|
| Vinblastine | 1 | 1995 | 502 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2001 | 1257 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2001 | 1533 | 0.010 |
Why?
|
| Cerebellum | 1 | 2001 | 1488 | 0.010 |
Why?
|
| Sarcoma, Kaposi | 1 | 1996 | 370 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 3567 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2938 | 0.010 |
Why?
|
| Insulin | 1 | 2008 | 6580 | 0.010 |
Why?
|
| Glutathione | 1 | 1995 | 589 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3846 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 592 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1995 | 675 | 0.010 |
Why?
|
| Culture Media | 1 | 1995 | 908 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2001 | 2751 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1995 | 597 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 2004 | 39050 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3494 | 0.010 |
Why?
|
| Brain | 3 | 2013 | 26385 | 0.010 |
Why?
|
| Nifedipine | 1 | 1993 | 226 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1351 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2000 | 1951 | 0.010 |
Why?
|
| Verapamil | 1 | 1993 | 244 | 0.010 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 1993 | 114 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1992 | 158 | 0.010 |
Why?
|
| Radiotherapy Dosage | 2 | 1989 | 2879 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1994 | 730 | 0.010 |
Why?
|
| Algorithms | 1 | 2012 | 13881 | 0.010 |
Why?
|
| Bombesin | 1 | 1991 | 34 | 0.010 |
Why?
|
| Pathology | 1 | 1994 | 272 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1995 | 1792 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1801 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1991 | 141 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1994 | 11124 | 0.010 |
Why?
|
| Neutropenia | 1 | 1996 | 895 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1995 | 1465 | 0.010 |
Why?
|
| Codon | 1 | 1992 | 611 | 0.010 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1989 | 14 | 0.010 |
Why?
|
| Monocytes | 1 | 2000 | 2596 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1995 | 685 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1991 | 349 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1990 | 135 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2001 | 3036 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1993 | 581 | 0.010 |
Why?
|
| Pneumonia | 1 | 2001 | 2133 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 919 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1987 | 9239 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7722 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1993 | 1880 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1995 | 1092 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 1989 | 193 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2376 | 0.010 |
Why?
|
| Cell Movement | 1 | 2000 | 5217 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1996 | 1179 | 0.000 |
Why?
|
| Histones | 1 | 1998 | 2599 | 0.000 |
Why?
|
| Protein Binding | 1 | 2000 | 9386 | 0.000 |
Why?
|
| Mesna | 1 | 1987 | 66 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1995 | 20822 | 0.000 |
Why?
|
| Risk | 1 | 2000 | 9687 | 0.000 |
Why?
|
| Dactinomycin | 1 | 1987 | 318 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4456 | 0.000 |
Why?
|
| Cystitis | 1 | 1987 | 93 | 0.000 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 1986 | 15 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1990 | 865 | 0.000 |
Why?
|
| Intercostal Nerves | 1 | 1986 | 26 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1994 | 1161 | 0.000 |
Why?
|
| Exons | 1 | 1992 | 2437 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1987 | 647 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 40561 | 0.000 |
Why?
|
| Bone Marrow Diseases | 1 | 1987 | 231 | 0.000 |
Why?
|
| United States | 1 | 1992 | 69872 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1991 | 1547 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18370 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 5867 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1986 | 610 | 0.000 |
Why?
|
| Papillomaviridae | 1 | 1989 | 1119 | 0.000 |
Why?
|
| Plasma Cells | 1 | 1984 | 591 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 4253 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1986 | 1285 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1989 | 1855 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2002 | 15295 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1997 | 9959 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 19905 | 0.000 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1991 | 5221 | 0.000 |
Why?
|
| Heart Failure | 1 | 1996 | 10900 | 0.000 |
Why?
|